past
month
seen
dramat
world
event
escal
threat
global
sar
sever
acut
respiratori
syndrom
epidem
war
iraq
beam
live
daili
live
weekli
medic
journal
cover
event
contribut
debat
surround
event
continu
impact
work
live
critic
practition
worldwid
come
addit
burden
period
number
longawait
report
import
new
studi
publish
report
intern
sepsi
definit
confer
januari
us
nation
heart
lung
blood
institut
futur
research
direct
acut
lung
injuri
brussel
roundtabl
surviv
intens
care
final
reach
print
although
much
contain
within
stock
take
familiar
serv
valuabl
time
summari
concern
delay
public
negat
momentum
expert
panel
gener
complement
deliber
sepsi
definit
confer
martin
colleagu
report
major
epidemiolog
studi
sepsi
usa
conduct
overal
pictur
present
confirm
incid
tripl
mortal
rate
fallen
year
proport
patient
organ
failur
increas
wherea
averag
hospit
stay
fell
day
white
femal
appear
least
vulner
group
given
studi
methodolog
complex
surround
definit
sepsi
draw
detail
conclus
problemat
studi
undoubtedli
provid
evid
support
enorm
ongo
effort
tackl
phenomenon
background
global
epidem
obes
impact
bodi
mass
index
shortterm
outcom
critic
ill
investig
tremblay
bandi
larg
popul
studi
north
american
median
intens
care
unit
icu
stay
day
fiftysix
per
cent
patient
admit
icu
overweight
obes
sever
obes
unsurprisingli
investig
found
underweight
associ
excess
mortal
overweightobesesever
obes
appear
fair
wors
normal
compatriot
overweightobesesever
obes
howev
longer
durat
icu
hospit
stay
excess
function
disabl
hospit
discharg
thu
high
bodi
mass
index
appear
predict
shortterm
outcom
place
addit
burden
health
care
resourc
valuabl
longterm
followup
data
survivor
critic
ill
spent
day
intens
care
present
fletcher
colleagu
report
alarmingli
high
incid
peripher
neurolog
deficit
examin
commentari
recent
publish
paper
small
piec
puzzl
longterm
view
subject
ongo
partial
denerv
muscl
subject
studi
reinforc
mani
issu
identifi
angu
colleagu
reinforc
need
longer
term
follow
outcom
variabl
clinic
studi
critic
ill
opposit
end
tempor
spectrum
wik
colleagu
report
effect
min
cardiopulmonari
resuscit
prior
defibril
outofhospit
cardiac
arrest
major
patient
whose
respons
time
min
intervent
significantli
improv
chanc
individu
surviv
year
versu
goe
dogma
immedi
defibril
support
previou
work
discuss
accompani
editori
author
suggest
key
issu
becom
rapidli
establish
durat
ventricular
fibril
order
establish
patient
might
benefit
approach
howev
advantag
establish
defibril
prior
min
cardiopulmonari
resuscit
nt
outofhospit
arrest
receiv
manoeuvr
sinc
renaiss
lowdos
glucocorticoid
septic
shock
concern
regard
immunolog
effect
intervent
voic
keh
colleagu
conduct
detail
crossov
trial
investig
give
hydrocortison
continu
infus
mgday
demonstr
well
recogn
haemodynam
benefit
establish
steroid
dose
patient
septic
shock
lead
downregul
proand
antiinflammatori
cascad
enhanc
neutrophil
phagocytosi
monocyt
function
crossov
design
result
rapid
withdraw
steroid
hour
caus
neg
rebound
effect
haemodynam
inflammatoryimmunolog
paramet
studi
provid
evid
addit
benefici
role
steroid
dose
may
play
patient
septic
shock
immun
enhanc
inflammatori
modul
mani
question
remain
regard
optim
use
simpl
arguabl
physiolog
intervent
sceptic
would
appear
receiv
blow
three
recent
public
add
insight
ventilatori
manag
patient
adult
respiratori
distress
syndrom
ard
anim
human
evid
support
hypothesi
ventilatorinduc
lung
injuri
caus
distant
organ
damag
pulmonari
product
apoptosisinduc
solubl
mediat
provid
eleg
set
experi
conduct
imai
cowork
reduc
effect
employ
lung
protect
strategi
gerlach
colleagu
demonstr
benefit
inhal
nitric
oxid
adult
ard
small
random
control
trial
patient
also
establish
efficaci
term
improv
arteri
oxygen
tensionfract
inspir
oxygen
ratio
dose
respons
attenu
continu
administr
wherea
maintain
control
patient
sure
studi
bodi
evid
preced
sound
death
knell
inhal
nitric
oxid
ard
final
old
fashion
intervent
receiv
vote
resurrect
cyclic
sigh
recruit
manoeuvr
receiv
littl
attent
recent
year
pelosi
colleagu
ad
previou
work
area
studi
investig
efficaci
sign
recruit
supin
prone
posit
demonstr
potenti
valu
combin
sigh
ventil
prone
posit
ard
patient
ad
bodi
evid
support
investig
theoret
attract
strategi
caveat
today
intervent
improv
oxygen
ard
shown
lead
outcom
benefit
novel
opiat
receptor
antagonist
recent
investig
promotil
agent
enhanc
enter
feed
meissner
cowork
stolen
march
manufactur
novel
agent
conduct
success
trial
enter
naloxon
ventil
patient
trial
naloxon
vers
erythromycin
vers
metoclopramid
wait
done
increas
interest
qualiti
quantiti
sleep
critic
ill
patient
experi
least
strong
associ
deprav
neuropsychiatr
sequela
gabor
colleagu
ad
field
investig
contribut
environment
stimuli
make
sleep
disrupt
normal
individu
mechan
ventil
patient
surprisingli
found
less
disrupt
attribut
nois
patient
care
activ
